Datavant company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

datavant.com

Founded Year

2017

Stage

Series B | Alive

Total Raised

$80.5M

Last Raised

$40M | 2 yrs ago

About Datavant

Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data.

Datavant Headquarter Location

2 Embarcadero Center 7th Floor

San Francisco, California, 94111,

United States

+1 415 525 1171

ESPs containing Datavant

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Biopharma Tech

Companies in this market offer alternative datasets that can supplement clinical trial data and improve the likelihood of trial success. These companies collect data from a variety of sources, such as patient registries, EHRs, insurance databases, social media, and patient research networks.

Datavant named as Leader among 15 other companies, including Syapse, Evidation, and Aetion.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Datavant

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Datavant in 3 CB Insights research briefs, most recently on Feb 2, 2022.

Expert Collections containing Datavant

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Datavant is included in 7 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

329 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

C

Conference Exhibitors

5,302 items

D

Digital Health

13,084 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

C

Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

B

Biopharma Tech

1,164 items

Datavant Patents

Datavant has filed 6 patents.

The 3 most popular patent topics include:

  • Data management
  • Cryptography
  • Information privacy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/14/2019

9/21/2021

Key management, Cryptography, Data management, Information privacy, Privacy

Grant

Application Date

11/14/2019

Grant Date

9/21/2021

Title

Related Topics

Key management, Cryptography, Data management, Information privacy, Privacy

Status

Grant

Latest Datavant News

Havas Health & You Partners with Datavant to Power Personalized Patient-Provider Advanced Intelligence Engine

Aug 4, 2022

San Francisco, California, UNITED STATES VersaiSM , a Havas Health & You solution, Creates privacy protected 360-degree View of Patient and Provider Journeys Powered by Connected Medical and Consumer Data Sets NEW YORK and SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Datavant, the leader in helping organizations securely connect health data, has partnered with Havas Health & You (HH&Y), the world's largest global health network – specializing in communications, education, and innovation – to power Versai’s patient and healthcare provider advanced intelligence engine. Versai enables HH&Y health and wellness clients to identify, predict, and respond to patients and providers with confidence and speed. Versai’s advanced intelligence engine combines de-identified medical and consumer data, AI, technology and content to deliver personalized, omni-channel experiences that meet patient and healthcare provider (HCP) needs. Datavant will power Versai’s privacy and HIPAA compliant data connectivity with de-identified patient level matching, enabling the linkage of client 1st party data, 2nd and 3rd party data, survey data and engagement data. “Engaging patients and physicians in health decisions starts with data that helps you understand their personal health experiences and needs,” said Pat Thistlethwaite, Chief Experience Officer at HH&Y. “Versai will enable clients to complete the picture of patients’ health and its impact on their lives, and engage health providers with personalized experiences to build stronger relationships with their brands.” These rich, integrated patient datasets will support health and life sciences clients with multi-layered real world patient journey maps, comprehensive patient profiles, and predictive health intelligence for high precision targeting and engagement. Versai will provide similar insights about health professionals, enabling clients to understand each provider’s behavior as practitioners, their patient population, and their values as people. Together, these insights will help Versai create and orchestrate meaningful experiences that solve patients’ and providers’ problems in real time. “We are excited to partner with HH&Y to enable connectivity of patient and consumer data in a privacy protected manner,” noted Travis May, Founder and President of Datavant. “There is a need to have a fuller understanding of the factors that influence a person’s health which allows for better, data-backed decisions regarding patient care. The partnership between Datavant and HH&Y enables a richer view of patient journeys while protecting individual patient privacy.” About Datavant Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of patient health records across datasets. Learn more about Datavant at  www.datavant.com . About Havas Health & You Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Havas Life PR and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. Its customer-centric approach has the talent, tenacity and technology that health-and-wellness companies, brands and people need to thrive in today’s world. Media Contacts:

Datavant Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Datavant Rank

  • When was Datavant founded?

    Datavant was founded in 2017.

  • Where is Datavant's headquarters?

    Datavant's headquarters is located at 2 Embarcadero Center, San Francisco.

  • What is Datavant's latest funding round?

    Datavant's latest funding round is Series B.

  • How much did Datavant raise?

    Datavant raised a total of $80.5M.

  • Who are the investors of Datavant?

    Investors of Datavant include Roivant Sciences, Transformation Capital, Johnson & Johnson Innovation, Cigna Ventures, Flex Capital and 5 more.

  • Who are Datavant's competitors?

    Competitors of Datavant include Syapse, Owkin, Mendel.ai, ConcertAI, AllStripes, Verana Health, Holmusk, HealthVerity, Verantos, Aetion and 12 more.

You May Also Like

Owkin Logo
Owkin

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology.

Evidation Logo
Evidation

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.

Aetion Logo
Aetion

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

ConcertAI Logo
ConcertAI

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

Syapse Logo
Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.